You just read:

Adagio Medical Announces US FDA Investigational Device Exemption Approval With Conditions To Conduct A Clinical Study For Treatment Of Persistent Atrial Fibrillation Using The Ultra-Low Temperature Cryoablation System

News provided by

Adagio Medical, Inc.

19 Aug, 2019, 22:45 BST